Sabitlenmiş Tweet
Our story is out on @biorxivpreprint! Thank you to all of our coauthors and especially to the all the patients and their families that make human brain research possible. biorxiv.org/content/10.110…
English
Schlossmacher Lab
17 posts
Schlossmacher Lab
@MGS_Lab
A Parkinson's disease lab located at University of Ottawa. We focus on many different approaches to understand the pathogenesis of PD.
University of Ottawa Katılım Ocak 2020
44 Takip Edilen114 Takipçiler
English
Don't forget our annual barbecue #PDABBQ2022 is TOMORROW June 24th at NOON at Roger Guindon. Event is open to everyone. 🎉
English
Schlossmacher Lab retweetledi
Schlossmacher Lab retweetledi
Meta analysis suggests patients with various bacterial, viral, & fungal infections (Helicobacter pylori, hepatitis C virus, Malassezia, & pneumoniae) might have increased risk of #Parkinsons. Antiviral treatment of HCV could reduce the risk of PD
onlinelibrary.wiley.com/doi/full/10.10…
English
Schlossmacher Lab retweetledi
We are celebrating the timely Me and My Microbes exhibition @museumofnature with special announcement of funding from @CIHR_IRSC for microbiome research across Canada, including @UCalgary. Visit the exhibition until March 29.
English
On Thursday night, some members of our lab attended the VIP event for the Me & My Microbes exhibit at the @MuseumofNature!
English
Schlossmacher Lab retweetledi
New @ParkinsonsUK research suggests that a bacteria which boosts digestive health can slow – and even reverse – the build-up of a protein associated with Parkinson’s.
👉Find out more at parkinsons.org.uk/news/gut-bacte…
GIF
English
Our new #PhD student Michaela Lunn gave an oral presentation at the recent OHRI Research Day in November and took home the first place prize! Michaela studies the immune properties of PD-linked protein #LRRK2. @OttawaHospital
English
Meet our senior #PhD candidate Daniel El Kodsi. Daniel has been producing exciting work in the Schlossmacher lab for many years. Stay tuned for exciting #firstauthor papers from Daniel coming soon!
English
A word cloud from the final thesis of our Master's student, Christopher Rousso, who successfully defended his thesis in November. Chris has done exciting work on the role of alpha-synuclein in the #immunesystem both in the brain and the periphery.
English
Schlossmacher Lab retweetledi
Dr. Michael Schlossmacher's research aims to unravel some of the mystery around #Parkinson’s, a disease for which there is no cure, or even a way to slow the progress.
His team's latest study is a step in that direction.
ottawacitizen.com/news/local-new… #onHWS @uOttawaBMRI @uottawa
English
Take a look at our paper from 2017 to see our findings on possible anti-microbial effects of #alphasynuclein and an exciting new staining technique created by our lab
The Science of Parkinson's@ScienceofPD
@topdresearch David Beckham's lab has shown that alpha synuclein has antiviral properties ( ncbi.nlm.nih.gov/pmc/articles/P… ), & Michael Schlossmacher's lab has a similar line of research (ncbi.nlm.nih.gov/pmc/articles/P…). So this new PARKIN research is interesting from this standpoint as well
English
Schlossmacher Lab retweetledi
Dr. Michael Schlossmacher speaking about Parkinson's research #letstalkparkinsons #tenderlovingresearch #TLR
English
Please see our most recently published paper in #STM for exciting research connecting PD-linked protein LRRK2 with an important role in immune defences. We also identified an interesting #sexdifference.
Science Translational Medicine@ScienceTM
A gene that has been linked to #Parkinsons disease controls the course of certain bacterial and viral infections in mice in a sex-specific manner. Read the new research from @uOttawa. #InfectiousDisease fcld.ly/e5q1x74
English